Speaker Profile
Charles Powell

Charles Powell MD, MBA

Internal Medicine, Pulmonary Disease, Critical Care Medicine
New York, New York, United States of America

Connect with the speaker?

Dr. Charles A. Powell, MD, MBA, is Professor of Medicine and System Division Chief for Pulmonary, Critical Care, and Sleep Medicine at the Icahn School of Medicine at Mount Sinai. He received his medical degree from the University of Chicago and trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine at Boston University. The primary focus of Dr. Powell’s clinical and research activities is lung nodules and cancer.

Dr. Powell is NIH-funded, has published over 150 articles, and directs an NIH-funded translational sciences laboratory that examines the genomics of lung cancer. A particular area of focus is on deconvoluting the biology and genomics of early-stage lung adenocarcinoma, for which recent advances have modified the diagnosis and approach to these tumors. He also directs research programs focused on applications of machine learning and artificial intelligence to advance the diagnosis and treatment of respiratory diseases.

Dr. Powell is the Director of the Mount Sinai Respiratory Institute, which brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, lung cancer, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and bronchiectasis. He was the founding chair of the American Thoracic Society Assembly on Thoracic Oncology, and he sees patients in consultation regarding lung nodules and lung cancer. Dr. Powell’s international reputation in the field is demonstrated by his election as President of the Fleischner Society and by his leadership roles in the International Society of Respiratory Disease.

He is chair of the International Multidisciplinary Adjudication Committee to evaluate interstitial lung disease adverse events in cancer clinical trials of antibody-drug conjugates that are sponsored by Daiichi Sankyo Inc. and AstraZeneca Ltd. The state of Florida requires out-of-state professionals registered to provide telehealth services to include a hyperlink to the Florida Department of Health telehealth webpage. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)